Evidence map›Paper›PMID 29682517›Full record

ArticleBioMed research international2018

Dihydromyricetin Attenuates TNF-

Dafeng Yang, Shenglan Tan, Zhousheng Yang, Pei Jiang, Caie Qin, Qiong Yuan, Ruili Dang, Xiaoxia Yao, Jian Qu, Qiong Lu and 4 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Regulation of Osteoclastogenesis and Bone Resorption by miRNAs.Frontiers in cell and developmental biology · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Dafeng YangDepartment of Pharmacy, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.ORCID 0000-0002-8320-8215
Shenglan TanDepartment of Pharmacy, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
Zhousheng YangDepartment of Pharmacy, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Hunan 530021, China.
Pei JiangDepartment of Clinical Pharmacy and Pharmacology, Jining First People's Hospital, Jining Medical University, Jining 272000, China.ORCID 0000-0002-8360-7427
Caie QinDepartment of Pharmacy, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
Qiong YuanNew Drugs Innovation and Development Institute, Department of Pharmacy, College of Medicine, Wuhan University of Science and Technology, Wuhan, Hubei 430065, China.
Ruili DangDepartment of Clinical Pharmacy and Pharmacology, Jining First People's Hospital, Jining Medical University, Jining 272000, China.
Xiaoxia YaoDepartment of Surgery, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
Jian QuDepartment of Pharmacy, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
Qiong LuDepartment of Pharmacy, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
Ping XuDepartment of Pharmacy, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
Bikui ZhangDepartment of Pharmacy, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
Daxiong XiangDepartment of Pharmacy, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
Lei ChenDepartment of Pharmacy, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.ORCID 0000-0002-9327-1621
Central South University · CNJining First People's Hospital · CNThe People's Hospital of Guangxi Zhuang Autonomous Region · CNWuhan University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating studies demonstrate that dihydromyricetin (DMY), a compound extracted from Chinese traditional herb,

Indexed as

AmidohydrolasesArginineCells, CulturedDown-RegulationFlavonolsHumansHuman Umbilical Vein Endothelial CellsMicroRNAsNitric OxideNitric Oxide Synthase Type IIISignal TransductionTumor Necrosis Factor-alphaAmidohydrolasesArgininedihydromyricetindimethylargininaseFlavonolsMicroRNAsMIRN21 microRNA, humanNitric OxideNitric Oxide Synthase Type IIIN,N-dimethylarginineTumor Necrosis Factor-alpha

Identifiers

PMID29682517
PMCPMC5850903
OpenAlexW2792670065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.